At this exhibition, Diagreat proudly unveils its cutting-edge high-efficiency therapeutic drug monitoring (TDM) system solution, integrating three core technologies to redefine industry standards through technological innovation. Leveraging the company's years of expertise in in vitro diagnostics, this solution revolutionizes the entire process chain—from sample processing to result interpretation. The fully automated pre-processing system rapidly handles samples, the TDM testing platform ensures data accuracy, and the MIPD prediction system interprets test results. Together, they achieve full-process intelligence, eliminating cumbersome operations and making drug concentration monitoring faster, more accurate, and simpler—providing robust support for precision medication!

Diagreat Bio's booth remained packed throughout the entire exhibition, with its new intelligent solutions drawing numerous domestic and international clients to stop and inquire. International customers from Europe, the Middle East, Southeast Asia, and other regions showed keen interest in our products. They either closely observed the equipment at the booth or sat down with our technical and sales teams for in-depth technical discussions and cooperation negotiations. After a detailed briefing, a client from the Middle East remarked: “Danda's comprehensive solution precisely addresses the efficiency and accuracy challenges our laboratory faces in TDM testing. Its level of intelligence is truly impressive.” The lively atmosphere of on-site exchanges not only affirmed the strength of Danda's products but also highlighted the powerful international appeal of Chinese smart manufacturing in the in vitro diagnostics sector.

This trip to CMEF Guangzhou proved to be a highly productive journey for Diagreat. Not only did we successfully showcase our technological prowess and innovative achievements in the TDM field to the global market, securing numerous potential cooperation opportunities, but we also gained valuable market insights through direct exchanges with industry experts and users. These insights have injected fresh inspiration into our future product iterations and R&D direction.

Diagreat will continue to deepen our commitment to precision medicine, driven by technological innovation, continuously optimizing and refining our products and services. We are dedicated to bringing more advanced and convenient testing solutions to markets across China and the world. Together with our partners, we will advance personalized medicine and contribute the “Diagreat Force” to the cause of human health! Though the grand event has concluded, our journey continues.

We extend our gratitude to all our friends, both new and old, for your support and attention. We look forward to our next gathering, where we will join hands to create an even brighter future!